I think once its get traction then we can get better picture, still early in game (1st inning) boys.
5.5% improvement surpasses gains by Contrave and Qsymia, Belviq growth during the holiday week points to a likely better performance over the next quarter with no major holidays.
Anything out there, are they launching today, what's out there boys?
day after day we see nothing, why is this stock so hated.
By a 7-2 margin, the Supreme Court has ruled in favor of Teva Pharmaceuticals in its patent suit against generic drugmakers, thereby reversing a federal appeals court (CAFC) decision that declared a patent in dispute was invalid, and sending the case back for further review.Vringo (NASDAQ:VRNG) appears to have gotten a lift from the ruling. The company is a month removed from stating it will seek a Supreme Court review of the CAFC's adverse ruling against Vringo regarding its infringement suit against Google, after the CAFC denied a petition for an en banc review of its decision. (hat tip: Patent Plays)